Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
Authors: Thanyawee Puthanakit
Linda Aurpibul
Sutee Yoksan
Thira Sirisanthana
Virat Sirisanthana
Chiang Mai University
Mahidol University
Keywords: Immunology and Microbiology;Medicine;Veterinary
Issue Date: 28-Nov-2007
Citation: Vaccine. Vol.25, No.49 (2007), 8257-8261
Abstract: HIV-infected children are vulnerable to infections by vaccine preventable pathogens. However, they have poorer responses to childhood immunization than healthy children. The objectives of this study are to determine the prevalence of Japanese encephalitis (JE) protective antibody in HIV-infected children with immune recovery after highly active antiretroviral therapy (HAART) and evaluate response to JE revaccination. JE neutralizing antibody titer of plasma was determined by a plaque reduction neutralization assay. An antibody titer of more than 1:10 was defined as protective antibody. Children who did not have protective antibody to JE were enrolled to receive a two-dose JE revaccination during the study. There were 96 children with mean age of 9.7 years (S.D. 2.6) and mean CD4 percentage of 25 (S.D. 5) who participated in the study. Forty-four children (46%) had protective antibody to JE. A two-dose JE revaccination was administered to 50 children who did not have JE antibody. At 1 month after revaccination, 44 children (88%) developed protective antibody. This study demonstrated that there is a low prevalence of JE protective antibody in HIV-infected children despite history of JE primary childhood vaccination. However, the majority of HIV-infected children with immune recovery after HAART can develop protective antibody after JE revaccination. © 2007 Elsevier Ltd. All rights reserved.
ISSN: 0264410X
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.